Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
45.25    2.75 (6.47%)
Bid:
44.50
Ask:
46.00
Spread: 1.50 (3.371%)
Market Cap: £86.82m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

IofinaEX Application Conditionally Approved

13 Jun 2019 07:00

RNS Number : 0370C
Iofina PLC
13 June 2019
 

THE INFORMATION COMMUNICATED IN THIS ANNOUNCEMENT IS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 596/2014.

 

 

13 June 2019

 

Iofina plc

("Iofina", the "Group", or the "Company")

(LSE AIM: IOF)

 

IofinaEX Application Conditionally Approved

 

Iofina, specialists in the exploration and production of iodine and manufacturers of high quality specialty chemical products, is pleased to provide an update on the development of its new subsidiary, IofinaEX Inc. ("IofinaEX").

IofinaEX, which will explore the production of CBD oils (a mixture of cannabinoids including cannabidiol) and other valuable compounds and uses of industrial hemp, has received conditional approval for its Hemp Processor/Handler License Application from the Kentucky Department of Agriculture. Although IofinaEX will be restricted from processing hemp until fee payments and a scheduled orientation are complete, it is expected that these events should be complete by mid-July, at which time research can begin.

Since the 2018 Agriculture Improvement Act ("2018 Farm Bill") legalised the cultivation of hemp at a federal level, new opportunities have opened up for the CBD market in the USA. IofinaEX, which is in research and planning stages, will utilise the Group's specialty chemistry knowledge and apply it to the extraction and isolation of purified CBD products. The new subsidiary would complement the specialty chemical products Iofina provides to global markets.

Commenting, President and CEO Dr. Tom Becker stated: ''The Directors are determined to explore the isolation of CBD oil and other valuable products from hemp, a market which is currently underdeveloped but rapidly growing. Iofina's expertise in speciality chemicals makes the new venture a suitable addition to the Iofina Group.

 

"The conditional approval for our Handler/Processor License in Kentucky is an important step forward as we plan to execute the project at IofinaEX, and we look forward to updating the market as we develop this subsidiary further."

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Matthew Radley (corporate finance)

Camille Gochez (ECM)

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Media Contact:

Charles Goodwin/Harriet Jackson

Yellow Jersey PR Limited

Tel: +44 (0)7544 275 882

About Iofina:

Iofina specialises in the exploration and production of iodine, and manufacturing of specialty chemical compounds. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America, based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Kentucky and Oklahoma. It is a vertically integrated company, covering the process from the production of iodine in the field, to the manufacture of the chemical end-products derived from iodine, supplying them to the consumer, and the recycling of iodine using iodinated side-streams from waste chemical processes. Additionally, Iofina utilises its expertise in specialty chemical manufacturing to produce non-iodine based products as well. Iofina utilises its portfolio of patented and patent-pending technology, and proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSFUESEFUSELM
Date   Source Headline
2nd Oct 20132:40 pmRNSHolding(s) in Company
26th Sep 20133:32 pmRNSHolding(s) in Company
25th Sep 20137:00 amRNSHalf Yearly Report
19th Sep 20137:00 amRNSDirectorate Change
6th Sep 20137:00 amRNSNotice of Results
16th Aug 20137:00 amRNSBoard Appointment
2nd Aug 20138:30 amRNSIOSorb Patent Awarded
1st Aug 20137:00 amRNSOperational Update
4th Jul 20138:56 amRNSDirector/PDMR Shareholding
3rd Jul 20135:40 pmRNSChange of Registered Office
28th Jun 20132:05 pmRNSDirector/PDMR Shareholding
25th Jun 20138:15 amRNSProduction & Produced Water Congress 2013
24th Jun 20132:22 pmRNSHolding(s) in Company
24th Jun 201312:00 pmRNSResponse to Share Price Movement
19th Jun 20132:10 pmRNSResult of AGM
19th Jun 20137:00 amRNSAGM Statement
17th Jun 20135:01 pmRNSHolding(s) in Company
12th Jun 201310:08 amRNSBoard Changes
5th Jun 20137:00 amRNSPosting of Annual Report and Notice of AGM
20th May 20137:00 amRNSCompletion of US$15m Convertible Bond Issue
8th May 20137:00 amRNSSuccessful Arrangement of US$15m Convertible Bond
7th May 20137:00 amRNSFinal Results
2nd May 20137:00 amRNSChange in Reporting Currency
29th Apr 20137:47 amRNSNotice of Final Results
29th Apr 20137:00 amRNSAtlantis Water Project Update
17th Apr 20137:00 amRNSHolding(s) in Company
15th Apr 20137:00 amRNSBoard Update
3rd Apr 20135:30 pmRNSHolding(s) in Company
28th Mar 20137:55 amRNSAtlantis Water Project
27th Mar 20134:09 pmRNSHolding(s) in Company
11th Mar 20135:19 pmRNSHolding(s) in Company
7th Mar 20137:00 amRNSOperational Update
11th Feb 20131:34 pmRNSHolding(s) in Company
16th Jan 20137:00 amRNSHolding(s) in Company
14th Jan 20137:00 amRNSAppointment of Non-Executive Director
11th Jan 20137:00 amRNSCommissioning of IO#2 IOsorbT Plant
20th Dec 20128:12 amRNSHolding(s) in Company
18th Dec 20129:00 amRNSHolding(s) in Company
4th Dec 20127:00 amRNSProduction Update
17th Sep 20127:00 amRNSHalf Yearly Report
6th Sep 20127:00 amRNSNotice of Results
16th Aug 20127:00 amRNSCommissioning of Plant
31st Jul 20127:00 amRNSCompletion of Construction of IO#1 IOsorb Plant
20th Jun 20122:25 pmRNSResult of AGM
20th Jun 20127:00 amRNSPurchase of Iodine Extraction Facility
7th Jun 20127:00 amRNSHolding(s) in Company
25th May 20127:00 amRNSPlacing to raise £4.3 million
25th May 20127:00 amRNSFinal Results
19th Apr 20127:56 amRNSAppointment of Investec as Nomad and Sole Broker
10th Apr 20129:39 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.